Dennis W. Pullin
Known title: DirectorCIK: 0001861249
Associated companies
Transaction History
| DVA | ▲ Buy | Grant | 278 | $0 | 8/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 250 | $0 | 5/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 332 | $0 | 3/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 411 | $0 | 11/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 369 | $0 | 8/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 348 | $0 | 5/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 349 | $0 | 3/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 312 | $0 | 11/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 300 | $0 | 8/15/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer
Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer. Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.